Clinical trials: Epigenomics
Aging
Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging
Assessing the effects of Quercitin and Dasatinib over a 16 week period on participatns' epigenetic biological aging. The patients are being tested at baseline, halfway point, and after the trial period.
- Trial name
- NCT04946383
- Testing
- Dasatinib plus Quercetin
- Where
- United States
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- TruDiagnostic
Burn Pit Exposure, Airborne Hazard Exposure
Project PHOENIX: Molecular Signatures of Burn Pit Exposure
Project PHOENIX is an observational clinical research study designed to characterize molecular, genomic, cellular, and functional features in blood specimens from former U.S.
- Conditions
- Burn Pit Exposure, Airborne Hazard Exposure, Veteran Health, Deployment-Related Toxic Exposure
- Trial name
- PHOENIX (NCT07562243)
- Testing
- Prior Burn Pit Exposure, No Known Burn Pit Exposure
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Creative Medical Technology Holdings Inc
Retinoid, Skin Aging
A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Using Non-invasive Measurements
This study is being conducted to confirm whether skin tape stripping methodology can identify changes in gene expression (i.e. whether different genes are turned on to make proteins) in aged skin after use of a retinoid.
- Conditions
- Retinoid, Skin Aging, Epigenomics
- Trial name
- NCT06658847
- Testing
- Night Cream Usage, No Night Cream Usage
- Where
- United States
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
Diagnosis of Cancer of Various Organs
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
ClearNote Health is developing a test from whole blood for the early detection of multiple cancers. The goal of this study is to employ genomics, epigenomics and proteomics methodology for the detection of cancer signal in the…
- Trial name
- NCT03869814
- Testing
- Blood Draw
- Where
- United States
- Volunteers
- 20,000 people, healthy volunteers welcome
- Sponsor
- ClearNote Health